Literature DB >> 25058312

Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.

Salvatore Giunta1, Violetta Andriolo2, Alessandro Castorina3.   

Abstract

In a previous work we have shown that exposure to aluminum (Al) chloride (AlCl3) enhanced the neurotoxicity of the amyloid beta(25-35) fragment (Abeta(25-35)) in neuroblastoma cells and affected the expression of Alzheimer's disease (AD)-related genes. Caffein, a compound endowed with beneficial effects against AD, exerts neuroprotection primarily through its antagonist activity on A2A adenosine receptors (A2AR), although it also inhibits A1Rs with similar potency. Still, studies on the specific involvement of these receptors in neuroprotection in a model of combined neurotoxicity (Abeta(25-35)+AlCl3) are missing. To address this issue, cultured SH-SY5Y cells exposed to Abeta(25-35)+AlCl3 were assessed for cell viability, morphology, intracellular ROS activity and expression of apoptosis-, stress- and AD-related proteins. To define the role of A1R and A2ARs, pretreatment with caffein, specific receptor antagonists (DPCPX or SCH58261) or siRNA-mediated gene knockdown were delivered. Results indicate that AlCl3 treatment exacerbated Abeta(25-35) toxicity, increased ROS production, lipid peroxidation, β-secretase-1 (BACE1) and amyloid precursor protein (APP). Interestingly, SCH58261 successfully prevented toxicity associated to Abeta(25-35) only, whereas pretreatment with both DPCPX and SCH58261 was required to fully avert Abeta(25-35)+AlCl3-induced damage, suggesting that A1Rs might also be critically involved in protection during combined toxicity. The effects of caffein were mimicked by both N-acetyl cysteine, an antioxidant, and desferrioxamine, likely acting through distinct mechanisms. Altogether, our data establish a novel protective function associated with A1R inhibition in the setting of combined Abeta(25-35)+AlCl3 neurotoxicity, and expand our current knowledge on the potential beneficial role of caffein to prevent AD progression in subjects environmentally exposed to aluminum.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosine receptor; Aluminum; Alzheimer's disease; Caffein; Neurotoxicity

Mesh:

Substances:

Year:  2014        PMID: 25058312     DOI: 10.1016/j.biocel.2014.07.009

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  16 in total

Review 1.  The neuroprotective effects of caffeine in neurodegenerative diseases.

Authors:  Mahshad Kolahdouzan; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2017-04       Impact factor: 5.243

Review 2.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

3.  Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure.

Authors:  Hong-Fang Mei; Neha Poonit; Yi-Chun Zhang; Chu-Yuan Ye; Hui-Lin Cai; Chen-Yi Yu; Yong-Hai Zhou; Bei-Bei Wu; Jun Cai; Xiao-Hong Cai
Journal:  Mol Cell Biochem       Date:  2018-01-29       Impact factor: 3.396

4.  Hippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration.

Authors:  Hong Wang; Mengliang Ye; Lijuan Yu; Jianfeng Wang; Yuanxin Guo; Wenjuan Lei; Junqing Yang
Journal:  Behav Brain Funct       Date:  2015-02-18       Impact factor: 3.759

5.  The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?

Authors:  Rubina Marzagalli; Alessandro Castorina
Journal:  Neural Regen Res       Date:  2015-02       Impact factor: 5.135

Review 6.  G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs.

Authors:  Juan Zhao; Yulin Deng; Zhaotan Jiang; Hong Qing
Journal:  Front Aging Neurosci       Date:  2016-03-24       Impact factor: 5.750

Review 7.  CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection.

Authors:  Peiqing Chen; Wenjuan Zhao; Yanjie Guo; Juan Xu; Ming Yin
Journal:  Biomed Res Int       Date:  2016-06-27       Impact factor: 3.411

Review 8.  In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease.

Authors:  Anna Vuorimaa; Eero Rissanen; Laura Airas
Journal:  Contrast Media Mol Imaging       Date:  2017-11-20       Impact factor: 3.161

Review 9.  Role of purinergic receptors in the Alzheimer's disease.

Authors:  Marek Cieślak; Andrzej Wojtczak
Journal:  Purinergic Signal       Date:  2018-10-25       Impact factor: 3.765

Review 10.  Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease.

Authors:  Md Ezazul Haque; In-Su Kim; Md Jakaria; Mahbuba Akther; Dong-Kug Choi
Journal:  Front Cell Neurosci       Date:  2018-08-21       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.